Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase-facilitated PCI in acute myocardial infarction (ASSENT 4 PCI)
NCT00168792Phase 4Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2003
- Primary completion
- Jul 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 18
01
Overview
A Phase 4 trial of tenecteplase in myocardial infarction (MI), sponsored by Boehringer Ingelheim. Started Nov 2003; status: terminated.
02
Drugs
tenecteplase
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00168792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168792.